Uncontrolled hypertension or diabetes
Uncontrolled hypertension or uncontrolled diabetes within  days prior cycle , day 
Uncontrolled hypertension or diabetes
Have uncontrolled diabetes or have hypertension requiring more than  medications for control of hypertension.
Uncontrolled hypertension or diabetes
Uncontrolled diabetes or hypertension
Uncontrolled hypertension or uncontrolled diabetes within  days prior to start of treatment
Uncontrolled diabetes or hypertension
Uncontrolled hypertension, uncontrolled pulmonary hypertension or uncontrolled diabetes within  days prior to enrollment
Uncontrolled diabetes, hypertension or other medical conditions that may interfere with assessment of toxicity
Uncontrolled hypertension or uncontrolled diabetes
Must not have any uncontrolled hypertension or uncontrolled diabetes within  days prior to enrollment.
Uncontrolled hypertension or uncontrolled diabetes within  days prior to randomization
Patients who exhibit uncontrolled hypertension (>= / mmHg) or uncontrolled diabetes within  days prior to registration are NOT eligible for participation
Uncontrolled diabetes, heart disease, hypertension
Uncontrolled hypertension or diabetes.
Uncontrolled diabetes or uncontrolled hypertension within  days prior to first dose
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or uncontrolled diabetes despite medication
Uncontrolled hypertension or uncontrolled diabetes within  days prior to the first day of treatment
Uncontrolled hypertension or uncontrolled diabetes within  days prior to randomization
No uncontrolled hypertension or uncontrolled diabetes (as determined by the treating physician) within  days prior to cycle  day 
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or diabetes.
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or uncontrolled diabetes within  days prior to signing consent
Patients must not have uncontrolled diabetes, uncontrolled infection despite antibiotics or uncontrolled hypertension within  days prior to registration
Uncontrolled hypertension or diabetes
Uncontrolled diabetes, hypertension or other medical conditions at the time of transition to this study that may interfere with assessment of toxicity
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or uncontrolled diabetes within  days prior to randomization
Uncontrolled hypertension or uncontrolled diabetes within  days prior to randomization
Predisposing factors to retinal vein occlusion including uncontrolled hypertension, uncontrolled diabetes, uncontrolled hyperlipidemia, and coagulopathy.
Uncontrolled diabetes, hypertension or other medical conditions that may interfere with assessment of toxicity.
Have uncontrolled diabetes or have hypertension requiring more than  medications for control of hypertension.
Major co-morbidities (e.g., uncontrolled diabetes, hypertension, etc.)
History of chronic disease including diabetes, uncontrolled hypertension or thyroid disease
Uncontrolled chronic illness such as hypertension, diabetes, or heart failure
Predisposing factors to retinal vein occlusion, including uncontrolled hypertension, uncontrolled diabetes, uncontrolled hyperlipidemia, and coagulopathy
